Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease

C. A.D. Smith, C.R. Wolf, A. C. Gough, N. K. Spurr, P. N. Leigh, B. A. Summers, A. E. Harding, D. M. Maranganore, S. G. Sturman, A. C. Williams, A. H.V. Schapira

    Research output: Contribution to journalArticlepeer-review

    441 Citations (Scopus)


    The pathogenesis of Parkinson's disease may be influenced by genetic and environmental factors. Cytochrome P450 mono-oxygenases help to protect against toxic environmental compounds and individual variations in cytochrome P450 expression might, therefore, influence susceptibility to environmentally linked diseases. The frequency of mutant CYP2D6 alleles was studied in 229 patients with Parkinson's disease and 720 controls. Individuals with a metabolic defect in the cytochrome P450 CYP2D6-debrisoquine hydroxylase gene with the poor metaboliser phenotype had a 2·54-fold (95% Cl 1·51-4·28) increased risk of Parkinson's disease. Determination of CYP2D6 phenotype and genotype may help to identify those at greatest risk of Parkinson's disease and may also help to identify the environmental or metabolic agents involved in the pathogenesis of this disease.

    Original languageEnglish
    Pages (from-to)1375-1377
    Number of pages3
    JournalThe Lancet
    Issue number8806
    Publication statusPublished - 6 Jun 1992

    ASJC Scopus subject areas

    • General Medicine


    Dive into the research topics of 'Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease'. Together they form a unique fingerprint.

    Cite this